0
     

Report Added
Report already added
Ophthalmic Equipment Market by Product (Spectacles, Contact Lenses, OCT Scanner, Fundus Camera, Ultrasound,Perimeter,Autorefracter, Slit Lamp, Keratometer, Tonometer, Ophthalmoscope, IOL,OVDs), End User (Consumer, Hospitals) - Global Forecast to 2027

Ophthalmic Equipment Market by Product (Spectacles, Contact Lenses, OCT Scanner, Fundus Camera, Ultrasound,Perimeter,Autorefracter, Slit Lamp, Keratometer, Tonometer, Ophthalmoscope, IOL,OVDs), End User (Consumer, Hospitals) - Global Forecast to 2027

The global ophthalmic equipment market is projected to reach USD 80.9 Billion by 2027 from USD 63.4 Billion in 2022, at a CAGR of 5.0%. The growth of this market can largely be attributed to the increase in elderly population, rise in adoption of digital devices, and increasing prevalence of vision disorders.

“The vision care products segment accounted for the largest share of the ophthalmic equipment market, in 2021.”

Based on products, the ophthalmic equipment market is segmented into vision care products, surgical devices, and diagnostic and monitoring devices. The large share of vision care products segment is attributed to rising demand for different type of eyeglass lenses, the growing prevalence of myopia, and growing geriatric population.

“The consumer segment hold the largest share in the ophthalmic equipment market, by end user”

Based on end users, the ophthalmic equipment market is segmented into consumers, hospitals, specialty clinics and ambulatory surgery centres, and other end users. The large share of consumers can be attributed to factors such as the increasing prevalence of eye disorders among the geriatric population, increasing usage of digital gadgets, and growing adoption of spectacles and contact lenses among consumers.

“The APAC to witness the highest growth during the forecast period.”

Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2022–2027. Some of the major factors that are expected to drive the growth of the ophthalmic equipment market in the Asia Pacific region are the significant growth opportunities for ophthalmology device manufacturers in China and India, and significant demand for spectacles & contact lenses. Moreover, with developed economies reaching saturation, manufacturers and suppliers are expected to focus on Asian markets.

Break of primary participants was as mentioned below:
•By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
•By Designation – C-level–35%, Director-level–25%, Others–40%
•By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the Ophthalmic Equipment Market
The prominent players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc.(US), EssilorLuxottica (France), Canon (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Zeimer Ophthalmic Systems (Switzerland), Staar Surgical (US), Haag-Streit (Switzerland), Quantel Medical (US), Coburn Technologies, Inc. (US), FCI Ophthalmics (US), Matronix India Corporation (India), HEINE Optotechnik (Germany), Visionix (France), Neo Vision (Korea), Clear Lab (Singapore), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India).

Research Coverage:
The report analyzes the ophthalmic equipment market and aims at estimating the market size and future growth potential of this market based on various segments such as product, end user, and region.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
•Market Penetration: Comprehensive information on product portfolios offered by the top players in the ophthalmic equipment market. The report analyzes this market by product, and by end user.
•Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the ophthalmic equipment market
•Market Development: Comprehensive information on the lucrative emerging markets by product, and end user.
•Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global ophthalmic equipment market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and competitive leadership mapping in the ophthalmic equipment market.
Table of Contents

1INTRODUCTION50
1.1STUDY OBJECTIVES50
1.2MARKET DEFINITION AND SCOPE50
1.2.1INCLUSIONS AND EXCLUSIONS51
1.3MARKET SCOPE52
1.3.1MARKETS COVERED52
FIGURE 1OPHTHALMIC EQUIPMENT MARKET SEGMENTATION52
1.3.2MARKETS COVERED – BY REGION53
1.3.3YEARS CONSIDERED53
1.4CURRENCY CONSIDERED54
TABLE 1EXCHANGE RATES UTILIZED FOR CONVERSION TO USD54
1.5STAKEHOLDERS54
1.6SUMMARY OF CHANGES55
2RESEARCH METHODOLOGY56
2.1RESEARCH DATA56
FIGURE 2RESEARCH DESIGN56
2.1.1SECONDARY DATA56
2.1.1.1Key data from secondary sources57
2.1.2PRIMARY DATA58
FIGURE 3PRIMARY SOURCES59
2.1.2.1Key data from primary sources60
2.1.2.2Key industry insights60
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS61
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE PARTICIPANTS61
2.2MARKET SIZE ESTIMATION62
FIGURE 6MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS62
FIGURE 7BOTTOM-UP APPROACH: VISION CARE PRODUCTS COMPANY REVENUE ESTIMATION APPROACH63
FIGURE 8BOTTOM-UP APPROACH: OPHTHALMIC SURGICAL EQUIPMENT COMPANY REVENUE ESTIMATION APPROACH63
FIGURE 9BOTTOM-UP APPROACH: OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT COMPANY REVENUE ESTIMATION APPROACH64
2.2.1CAGR PROJECTIONS65
FIGURE 10CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS65
2.2.2TOP-DOWN APPROACH66
FIGURE 11DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ON MARKET GROWTH AND CAGR67

2.3MARKET BREAKDOWN AND DATA TRIANGULATION68
FIGURE 12DATA TRIANGULATION METHODOLOGY68
2.4MARKET SHARE ANALYSIS69
2.5RESEARCH ASSUMPTIONS69
2.6LIMITATIONS70
2.6.1METHODOLOGY-RELATED LIMITATIONS70
2.6.2SCOPE-RELATED LIMITATIONS70
2.7RISK ASSESSMENT70
TABLE 2RISK ASSESSMENT: OPHTHALMIC EQUIPMENT MARKET70
3EXECUTIVE SUMMARY71
FIGURE 13OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)71
FIGURE 14OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2022 VS. 2027(USD MILLION)72
FIGURE 15OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2022 VS. 2027 (USD MILLION)73
FIGURE 16CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)74
FIGURE 17VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)75
FIGURE 18OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2022 VS. 2027 (USD MILLION)76
FIGURE 19OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)77
FIGURE 20GEOGRAPHICAL SNAPSHOT OF OPHTHALMIC EQUIPMENT MARKET78
4PREMIUM INSIGHTS79
4.1OPHTHALMIC EQUIPMENT MARKET OVERVIEW79
FIGURE 21INCREASING EYE DISORDERS AND RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET79
4.2NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY AND END USER (2021)80
FIGURE 22CONSUMERS TO DOMINATE NORTH AMERICAN OPHTHALMIC EQUIPMENT MARKET IN 202180
4.3OPHTHALMIC EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES81
FIGURE 23INDIA TO REGISTER HIGHEST GROWTH RATE FROM 2022 TO 202781
4.4OPHTHALMIC EQUIPMENT MARKET, BY REGION (2020–2027)81
FIGURE 24NORTH AMERICA TO DOMINATE MARKET UNTIL 202781
4.5OPHTHALMIC EQUIPMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS82
FIGURE 25DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD82

5MARKET OVERVIEW83
5.1INTRODUCTION83
5.2MARKET DYNAMICS84
FIGURE 26OPHTHALMIC EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES84
5.2.1DRIVERS84
5.2.1.1Increasing geriatric population84
TABLE 3INCREASE IN GERIATRIC POPULATION, 2000–205085
5.2.1.2Rising prevalence of eye disorders85
TABLE 4GLOBAL PREVALENCE OF EYE DISORDERS, BY TYPE, 2021 (IN MILLION)86
5.2.1.2.1Cataracts86
TABLE 5NUMBER OF CATARACT SURGERIES, BY COUNTRY (2020 VS 2021)86
5.2.1.2.2Glaucoma86
TABLE 6NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2020 VS 2040 (IN MILLION)87
5.2.1.2.3Obesity and diabetes87
TABLE 7NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2030 VS 2045 (MILLION)87
5.2.1.2.4Age-related macular degeneration (AMD)88
TABLE 8NUMBER OF PEOPLE WITH AGE-RELATED MACULAR DEGENERATION, BY REGION, 2020 VS 2050 (MILLION)88
5.2.1.3Technological advancements in ophthalmic devices88
TABLE 9RECENT PRODUCT LAUNCHES IN OPHTHALMIC EQUIPMENT MARKET (2019–2021)89
5.2.1.4Increased government initiatives to control visual impairment89
5.2.1.5Rising adoption of contact lenses and spectacles90
TABLE 10PREVALENCE AND PATIENT POPULATION FOR MYOPIA, 2020–205090
5.2.2RESTRAINTS91
5.2.2.1High cost and risk associated with eye surgeries91
5.2.2.2Increased cost of ophthalmology devices91
TABLE 11PRICE OF OPHTHALMIC EQUIPMENT, BY TYPE (2021)92
5.2.2.3Rising adoption of refurbished ophthalmic devices92
5.2.3OPPORTUNITIES93
5.2.3.1Potential growth opportunities in emerging markets93
5.2.3.2Low adoption of phacoemulsification devices and premium IOLs in emerging regions93
5.2.4CHALLENGES94
5.2.4.1Low accessibility to eye care in low-income countries94
5.2.4.2Lack of skilled professionals94

6INDUSTRY INSIGHTS96
6.1INDUSTRY TRENDS96
6.1.1INNOVATIVE APPLICATION OF FEMTOSECOND LASER TECHNOLOGY96
6.1.2TECHNOLOGICAL ADVANCEMENT IN INTRAOCULAR LENSES96
6.1.3MINIMALLY INVASIVE GLAUCOMA SURGERY97
6.2PRICING ANALYSIS97
TABLE 12REGIONAL PRICING ANALYSIS OF OPHTHALMIC EQUIPMENT, 2021 (USD)98
6.2.1VISION CARE PRODUCTS PRICING ANALYSIS, BY KEY PLAYERS98
TABLE 13VISION CARE PRODUCTS PRICING ANALYSIS, BY KEY PLAYERS, 2021 (USD)98
6.2.2SURGICAL DEVICES PRICING ANALYSIS, BY KEY PLAYERS98
TABLE 14SURGICAL DEVICES PRICING ANALYSIS, BY KEY PLAYERS, 2021 (USD)98
6.2.3DIAGNOSTIC & MONITORING DEVICES PRICING ANALYSIS, BY KEY PLAYERS99
TABLE 15DIAGNOSTIC & MONITORING DEVICES PRICING ANALYSIS, BY KEY PLAYERS, 2021 (USD)99
6.3PATENT ANALYSIS99
6.3.1PATENT PUBLICATION TRENDS FOR OPHTHALMIC EQUIPMENT99
FIGURE 27PATENT PUBLICATION TRENDS (JANUARY 2011– AUGUST 2022)100
6.3.2INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS100
FIGURE 28TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR OPHTHALMIC EQUIPMENT PATENTS (JANUARY 2011–AUGUST 2022)101
FIGURE 29TOP APPLICANT COUNTRIES/REGIONS FOR OPHTHALMIC EQUIPMENT (JANUARY 2011–AUGUST 2022)102
TABLE 16LIST OF PATENTS/PATENT APPLICATIONS IN OPHTHALMIC EQUIPMENT MARKET, 2021–2022102
6.4VALUE CHAIN ANALYSIS104
FIGURE 30OPHTHALMIC EQUIPMENT MARKET: VALUE CHAIN ANALYSIS104
6.5SUPPLY CHAIN ANALYSIS105
FIGURE 31OPHTHALMIC EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS106
6.6ECOSYSTEM ANALYSIS106
TABLE 17OPHTHALMIC EQUIPMENT MARKET: ECOSYSTEM MAPPING107
TABLE 18OPHTHALMIC EQUIPMENT MARKET: ROLE IN ECOSYSTEM108
6.7PORTER’S FIVE FORCES ANALYSIS109
TABLE 19OPHTHALMIC EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS109
6.7.1THREAT OF NEW ENTRANTS109
6.7.2THREAT OF SUBSTITUTES109
6.7.3BARGAINING POWER OF BUYERS110
6.7.4BARGAINING POWER OF SUPPLIERS110
6.7.5DEGREE OF COMPETITION110
6.8REGULATORY ANALYSIS110
6.8.1NORTH AMERICA110
6.8.1.1US110
6.8.1.2Canada111
6.8.2EUROPE111
6.8.3ASIA PACIFIC111
6.8.3.1China111
6.8.3.2Japan112
6.8.3.3India112
6.8.4LATIN AMERICA112
6.8.4.1Brazil113
6.8.4.2Mexico113
6.8.5MIDDLE EAST113
6.8.6AFRICA113
6.9REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS114
TABLE 20NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS114
TABLE 21EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS114
TABLE 22ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS115
TABLE 23LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS115
6.10TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES116
6.10.1REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGICAL ADVANCED OPHTHALMIC EQUIPMENT DUE TO COVID-19 PANDEMIC116
FIGURE 32REVENUE SHIFT IN OPHTHALMIC EQUIPMENT MARKET116
6.11TRADE ANALYSIS117
6.11.1TRADE ANALYSIS FOR OPHTHALMIC EQUIPMENT PRODUCTS117
TABLE 24IMPORT DATA FOR ARTICLES AND EQUIPMENT FOR OPHTHALMIC EQUIPMENT PRODUCTS, BY COUNTRY, 2017–2021 (USD MILLION)117
TABLE 25EXPORT DATA FOR ARTICLES AND EQUIPMENT FOR OPHTHALMIC EQUIPMENT PRODUCTS, BY COUNTRY, 2017–2021 (USD MILLION)117
6.12KEY CONFERENCES AND EVENTS IN 2022−2023118
TABLE 26OPHTHALMIC EQUIPMENT MARKET: DETAILED LIST OF CONFERENCES AND EVENTS118
6.13KEY STAKEHOLDERS AND BUYING CRITERIA119
6.13.1KEY STAKEHOLDERS IN BUYING PROCESS119
FIGURE 33INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS119
TABLE 27INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS119
6.13.2BUYING CRITERIA120
FIGURE 34KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS120
TABLE 28KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS120
6.14CASE STUDY121

7OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT122
7.1INTRODUCTION123
TABLE 29OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)123
7.2VISION CARE PRODUCTS123
TABLE 30VISION CARE PRODUCTS OFFERED BY KEY PLAYERS124
TABLE 31OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)125
TABLE 32OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)125
7.2.1SPECTACLES126
7.2.1.1Rising adoption of digital devices to drive market126
TABLE 33SPECTACLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)127
7.2.2CONTACT LENSES127
TABLE 34CONTACT LENSES OFFERED BY KEY PLAYERS128
TABLE 35CONTACT LENSES MARKET, BY TYPE, 2020–2027 (USD MILLION)129
TABLE 36CONTACT LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)130
7.2.2.1Soft contact lenses130
7.2.2.1.1Increasing prevalence of myopia to propel adoption130
TABLE 37SOFT CONTACT LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)131
7.2.2.2RGP lenses131
7.2.2.2.1Increased usage of lenses to correct irregularly shaped corneas to drive demand131
TABLE 38RIGID GAS PERMEABLE LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)132
7.2.2.3Hybrid Contact Lenses133
7.2.2.3.1Hybrid lenses to provide advantages over soft and rigid lenses133
TABLE 39HYBRID CONTACT LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)133
7.3SURGICAL DEVICES134
TABLE 40OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)134
TABLE 41OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)135
7.3.1CATARACT SURGICAL DEVICES135
TABLE 42CATARACT SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)136
TABLE 43CATARACT SURGICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)136
7.3.1.1Intraocular lenses137
7.3.1.1.1Rising prevalence of cataracts globally to propel segment137
TABLE 44INTRAOCULAR LENSES OFFERED BY KEY PLAYERS138
TABLE 45INTRAOCULAR LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)139
7.3.1.2Ophthalmic viscoelastic devices139
7.3.1.2.1Increasing cataract surgeries to support market139
TABLE 46OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)141
7.3.1.3Phacoemulsification devices141
7.3.1.3.1Advancements in phacoemulsification devices to increase demand141
TABLE 47PHACOEMULSIFICATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)143
7.3.1.4Cataract surgical lasers143
7.3.1.4.1Accuracy and safety of femtosecond laser technology to drive demand143
TABLE 48CATARACT SURGICAL LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)145
7.3.1.5IOL injectors145
7.3.1.5.1Rising need for accurate implantation to boost market145
TABLE 49IOL INJECTORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)146
TABLE 50IOL INJECTORS OFFERED BY KEY PLAYERS146
7.3.2VITREORETINAL SURGICAL DEVICES147
TABLE 51VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)147
TABLE 52VITREORETINAL SURGICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)148
7.3.2.1Vitrectomy machines148
7.3.2.1.1Vitrectomy machines to correct retinal errors148
TABLE 53VITRECTOMY MACHINES OFFERED BY KEY PLAYERS149
TABLE 54VITRECTOMY MACHINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)149
7.3.2.2Vitreoretinal packs150
7.3.2.2.1Increasing awareness about vitreoretinal surgery to drive demand150
TABLE 55VITREORETINAL PACKS OFFERED BY KEY PLAYERS150
TABLE 56VITREORETINAL PACKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)151
7.3.2.3Photocoagulation lasers151
7.3.2.3.1Rising prevalence of various eye diseases to drive market151
TABLE 57PHOTOCOAGULATION LASERS OFFERED BY KEY PLAYERS152
TABLE 58PHOTOCOAGULATION LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)152
7.3.2.4Illumination devices153
7.3.2.4.1Portability and power to increase efficiency153
TABLE 59ILLUMINATION DEVICES OFFERED BY KEY PLAYERS153
TABLE 60ILLUMINATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)154
7.3.2.5Vitrectomy probes154
7.3.2.5.1Advancements to rapidly cut speed to remove vitreous bodies154
TABLE 61VITRECTOMY PROBES OFFERED BY KEY PLAYERS155
TABLE 62VITRECTOMY PROBES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)155

7.3.3REFRACTIVE SURGICAL DEVICES156
TABLE 63REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)156
TABLE 64REFRACTIVE SURGICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)157
7.3.3.1Femtosecond lasers157
7.3.3.1.1Preference for femtosecond lasers over microkeratomes to support market157
TABLE 65FEMTOSECOND LASERS OFFERED BY KEY PLAYERS158
TABLE 66FEMTOSECOND LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)159
7.3.3.2Excimer lasers159
7.3.3.2.1Increased occurrence of myopia to drive market159
TABLE 67EXCIMER LASERS OFFERED BY KEY PLAYERS160
TABLE 68EXCIMER LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)160
7.3.3.3Other refractive surgical lasers161
TABLE 69OTHER REFRACTIVE SURGICAL LASERS OFFERED BY KEY PLAYERS161
TABLE 70OTHER REFRACTIVE SURGICAL LASERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)162
7.3.4GLAUCOMA SURGICAL DEVICES162
TABLE 71GLAUCOMA SURGICAL DEVICES OFFERED BY KEY PLAYERS163
TABLE 72GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)163
TABLE 73GLAUCOMA SURGICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)164
7.3.4.1Microinvasive glaucoma surgery devices164
7.3.4.1.1Rising preference for microinvasive glaucoma surgery to drive adoption164
TABLE 74MICROINVASIVE GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)165
7.3.4.2Glaucoma drainage devices166
7.3.4.2.1Rising prevalence of glaucoma globally to propel market166
TABLE 75GLAUCOMA DRAINAGE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)167
7.3.4.3Glaucoma laser systems167
7.3.4.3.1Increasing prevalence of open-angle glaucoma to drive market167
TABLE 76GLAUCOMA LASER SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)168
7.3.5OPHTHALMIC MICROSCOPES169
7.3.5.1Rising occurrence of eye diseases to boost segment169
TABLE 77OPHTHALMIC MICROSCOPES OFFERED BY KEY PLAYERS169
TABLE 78OPHTHALMIC MICROSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)170
7.3.6OPHTHALMIC SURGICAL ACCESSORIES170
TABLE 79OPHTHALMIC SURGICAL ACCESSORIES OFFERED BY KEY PLAYERS171
TABLE 80OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)172
TABLE 81OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)173
7.3.6.1Surgical sets & instruments173
7.3.6.1.1Surgical sets & instruments to dominate market173
TABLE 82SURGICAL SETS & INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)174
7.3.6.2Ophthalmic tips & handles174
7.3.6.2.1Wide range of tips and handles to drive demand174
TABLE 83OPHTHALMIC TIPS& HANDLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)175
7.3.6.3Ophthalmic scissors175
7.3.6.3.1Titanium scissors to dominate segment175
TABLE 84OPHTHALMIC SCISSORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)176
7.3.6.4Ophthalmic forceps176
7.3.6.4.1Forceps to be mostly used in ophthalmological surgeries176
TABLE 85OPHTHALMIC FORCEPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)177
7.3.6.5Ophthalmic spatulas177
7.3.6.5.1China to be fastest-growing market for ophthalmic spatulas177
TABLE 86OPHTHALMIC SPATULAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)178
7.3.6.6Macular lenses178
7.3.6.6.1Increased adoption of macular lenses to drive segment178
TABLE 87MACULAR LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)179
7.3.6.7Ophthalmic cannulas179
7.3.6.7.1Rising adoption of single-use cannulas to drive market179
TABLE 88OPHTHALMIC CANNULAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)180
7.3.6.8Other ophthalmic surgical accessories180
TABLE 89OTHER OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)181
7.4DIAGNOSTIC & MONITORING DEVICES181
TABLE 90OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)182
TABLE 91OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)183
7.4.1OPTICAL COHERENCE TOMOGRAPHY SCANNERS183
7.4.1.1OCT scanners to provide high-depth image analysis on real-time basis183
TABLE 92OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)184
TABLE 93OCT SCANNERS OFFERED BY KEY MARKET PLAYERS185
7.4.2FUNDUS CAMERAS185
7.4.2.1Rising age-related disorders to drive market185
TABLE 94FUNDUS CAMERAS OFFERED BY KEY MARKET PLAYERS186
TABLE 95FUNDUS CAMERAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)187
7.4.3PERIMETERS/VISUAL FIELD ANALYZERS187
7.4.3.1Increasing incidence of glaucoma and AMD to propel demand187
TABLE 96PERIMETERS/VISUAL FIELD ANALYZERS OFFERED BY KEY MARKET PLAYERS188
TABLE 97PERIMETERS/ VISUAL FIELD ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)188
7.4.4AUTOREFRACTORS & KERATOMETERS189
7.4.4.1Rising visually impaired patients to drive market189
TABLE 98AUTOREFRACTORS & KERATOMETERS OFFERED BY KEY MARKET PLAYERS189
TABLE 99AUTOREFRACTORS & KERATOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)190
7.4.5OPHTHALMIC ULTRASOUND IMAGING SYSTEMS190
TABLE 100OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)191
TABLE 101OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)191
7.4.5.1A-scan ultrasound imaging systems192
7.4.5.1.1Increased usage in cataract surgeries to propel market192
TABLE 102OPHTHALMIC A-SCAN ULTRASOUND IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS192
TABLE 103OPHTHALMIC A-SCAN ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)193
7.4.5.2B-scan ultrasound imaging systems193
7.4.5.2.1Assessment of eyes and orbits to detect eye disorders to drive market193
TABLE 104OPHTHALMIC B-SCAN ULTRASOUND IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS194
TABLE 105OPHTHALMIC B-SCAN ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)194
7.4.5.3Opthalmic UBM Ultrasound195
7.4.5.3.1Rising volume of refractive surgeries globally to drive market195
TABLE 106OPHTHALMIC ULTRASOUND BIOMICROSCOPES OFFERED BY KEY MARKET PLAYERS195
TABLE 107OPHTHALMIC ULTRASOUND BIOMICROSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)196
7.4.5.4Ophthalmic Pachymeters196
7.4.5.4.1Ophthalmic pachymeters to monitor cornea196
TABLE 108OPHTHALMIC PACHYMETERS OFFERED BY KEY MARKET PLAYERS197
TABLE 109OPHTHALMIC PACHYMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)198
7.4.6TONOMETERS198
7.4.6.1Rising prevalence of glaucoma to drive demand198
TABLE 110TONOMETERS OFFERED BY KEY MARKET PLAYERS199
TABLE 111TONOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)200

7.4.7SLIT LAMPS200
7.4.7.1Rising prevalence of ocular conditions to drive market200
TABLE 112SLIT LAMPS OFFERED BY KEY MARKET PLAYERS201
TABLE 113SLIT LAMPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)202
7.4.8PHOROPTERS202
7.4.8.1Phoropters to measure refractive errors202
TABLE 114PHOROPTERS OFFERED BY KEY MARKET PLAYERS203
TABLE 115PHOROPTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)204
7.4.9WAVEFRONT ABERROMETERS204
7.4.9.1Aberrometers to measure refractive aberrations204
TABLE 116WAVEFRONT ABERROMETERS OFFERED BY KEY MARKET PLAYERS205
TABLE 117WAVEFRONT ABERROMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)205
7.4.10OPTICAL BIOMETRY SYSTEMS206
7.4.10.1Advantages of optical biometry systems to boost diagnostics206
TABLE 118OPTICAL BIOMETRY SYSTEMS OFFERED BY KEY MARKET PLAYERS206
TABLE 119OPTICAL BIOMETRY SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)207
7.4.11OPHTHALMOSCOPES207
7.4.11.1Increasing patients with glaucoma, diabetic retinopathy, and AMD to drive market207
TABLE 120OPHTHALMOSCOPES OFFERED BY KEY MARKET PLAYERS208
TABLE 121OPHTHALMOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)209
7.4.12LENSMETERS209
7.4.12.1Rising prevalence of myopia and hyperopia with increasing adoption of glassware to drive market209
TABLE 122LENSMETERS OFFERED BY KEY MARKET PLAYERS210
TABLE 123LENSMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)211
7.4.13CORNEAL TOPOGRAPHY SYSTEMS211
7.4.13.1Rising LASIK procedures to propel demand211
TABLE 124CORNEAL TOPOGRAPHY SYSTEMS OFFERED BY KEY MARKET PLAYERS212
TABLE 125CORNEAL TOPOGRAPHY SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)212
7.4.14CHART PROJECTORS213
7.4.14.1Eye chart projectors to access different chart types in one device213
TABLE 126CHART PROJECTORS OFFERED BY KEY MARKET PLAYERS213
TABLE 127CHART PROJECTORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)214
7.4.15SPECULAR MICROSCOPES214
7.4.15.1Increasing diabetic patients to drive market214
TABLE 128SPECULAR MICROSCOPES OFFERED BY KEY MARKET PLAYERS215
TABLE 129SPECULAR MICROSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)215
7.4.16RETINOSCOPES216
7.4.16.1Rising prevalence of myopia globally to boost market216
TABLE 130RETINOSCOPES OFFERED BY KEY MARKET PLAYERS216
TABLE 131RETINOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)217
8OPHTHALMIC EQUIPMENT MARKET, BY END USER218
8.1INTRODUCTION219
TABLE 132OPHTHALMIC EQUIPMENT MARKET BY END USER, 2020–2027 (USD MILLION)219
8.2CONSUMERS219
8.2.1INCREASING OCULAR DISORDERS WITH RISING ADOPTION OF CONTACT LENSES AND SPECTACLES TO DRIVE MARKET219
TABLE 133OPHTHALMIC EQUIPMENT MARKET FOR CONSUMERS, BY COUNTRY, 2020–2027 (USD MILLION)220
8.3HOSPITALS220
8.3.1LARGE PATIENT POOL AND HIGH PURCHASING POWER FOR ADVANCED INSTRUMENTS TO PROPEL MARKET220
FIGURE 35NUMBER OF HOSPITALS, BY COUNTRY (2019)221
TABLE 134OPHTHALMIC EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)222
8.4SPECIALITY CLINICS AND AMBULATORY SURGERY CENTERS222
8.4.1COST-EFFECTIVENESS OF AMBULATORY CARE TO DRIVE MARKET222
FIGURE 36US: NUMBER OF AMBULATORY SURGICAL CENTERS (2012-2022)223
TABLE 135OPHTHALMIC EQUIPMENT MARKET FOR SPECIALITY CLINICS AND AMBULATORY SURGERY CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)224
8.5OTHER END USERS224
TABLE 136OPHTHALMIC EQUIPMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)225
9OPHTHALMIC EQUIPMENT MARKET, BY REGION226
9.1INTRODUCTION227
FIGURE 37OPHTHALMIC EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES227
TABLE 137OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)228
9.2NORTH AMERICA228
FIGURE 38NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET SNAPSHOT229
TABLE 138NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)230
TABLE 139NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)230
TABLE 140NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)231
TABLE 141NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)232
TABLE 142NORTH AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)232
TABLE 143NORTH AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)233
TABLE 144NORTH AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)233
TABLE 145NORTH AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)233
TABLE 146NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)234
TABLE 147NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)234
TABLE 148NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)234
9.2.1US235
9.2.1.1Rising geriatric population and increasing healthcare expenditure to drive market235
TABLE 149US: KEY MACROINDICATORS235
TABLE 150OCULAR CONDITIONS IN US: 2000–2020 (MILLION)236
TABLE 151US: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)236
TABLE 152US: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)237
TABLE 153US: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)238
TABLE 154US: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)238
TABLE 155US: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)239
TABLE 156US: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)239
TABLE 157US: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)239
TABLE 158US: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)240
TABLE 159US: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)240
TABLE 160US: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)240
9.2.2CANADA241
9.2.2.1Rising awareness about eye care and increasing ocular diseases to drive market241
TABLE 161CANADA: KEY MACROINDICATORS241
TABLE 162CANADA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)242
TABLE 163CANADA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)242
TABLE 164CANADA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)243
TABLE 165CANADA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)243
TABLE 166CANADA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)244
TABLE 167CANADA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)244
TABLE 168CANADA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)244
TABLE 169CANADA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)245
TABLE 170CANADA: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)245
TABLE 171CANADA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)245
9.3EUROPE246
TABLE 172EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)246
TABLE 173EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)247
TABLE 174EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)247
TABLE 175EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)248
TABLE 176EUROPE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)248
TABLE 177EUROPE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)249
TABLE 178EUROPE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)249
TABLE 179EUROPE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)249
TABLE 180EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)250
TABLE 181EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)250
TABLE 182EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)250
9.3.1GERMANY251
9.3.1.1Increasing healthcare expenditure to boost market251
TABLE 183GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)251
TABLE 184GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)252
TABLE 185GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)253
TABLE 186GERMANY: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)253
TABLE 187GERMANY: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)254
TABLE 188GERMANY: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)254
TABLE 189GERMANY: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)254
TABLE 190GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)255
TABLE 191GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)255
TABLE 192GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)255
9.3.2UK256
9.3.2.1Rising prevalence of diabetes-related eye diseases to drive market256
TABLE 193UK: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)256
TABLE 194UK: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)257
TABLE 195UK: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)258
TABLE 196UK: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)258
TABLE 197UK: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)259
TABLE 198UK: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)259
TABLE 199UK: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)259
TABLE 200UK: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)260
TABLE 201UK: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)260
TABLE 202UK: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)260
9.3.3FRANCE261
9.3.3.1Growing eye surgeries to drive demand261
TABLE 203FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)261
TABLE 204FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)262
TABLE 205FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (USD MILLION)263
TABLE 206FRANCE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)263
TABLE 207FRANCE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)264
TABLE 208FRANCE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)264
TABLE 209FRANCE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)264
TABLE 210FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)265
TABLE 211FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR CONTACT LENSES, BY TYPE, 2020–2027 (USD MILLION)265
TABLE 212FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)265
9.3.4ITALY266
9.3.4.1Increasing healthcare spending and growing geriatric population to propel market266
TABLE 213ITALY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)266
TABLE 214ITALY: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2020–2027 (USD MILLION)267
TABLE 215ITALY: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2020–2027 (U

Report Title: Ophthalmic Equipment Market by Product (Spectacles, Contact Lenses, OCT Scanner, Fundus Camera, Ultrasound,Perimeter,Autorefracter, Slit Lamp, Keratometer, Tonometer, Ophthalmoscope, IOL,OVDs), End User (Consumer, Hospitals) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM